药石科技 (300725.SZ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

20.3x

EV/EBITDA

27.6x

Market Cap

CNY 11.29B

MomentumView details →

1D Return

−6.12%

YTD Return

+10.81%

RSI (14)

42.8

ValuationView details →

P/E (Fwd)

20.3x

EV/EBITDA

27.6x

Market Cap

CNY 11.29B

RSI (14)

42.8

MomentumView details →

1D Return

−6.12%

YTD Return

+10.81%

ProfitabilityView details →

Gross Margin

31.26%

Net Margin

9.71%

EBITDA Margin

17.35%

ROE (TTM)

3.58%

ROA (TTM)

3.08%

Asset Turnover

0.30x

GrowthView details →

Revenue YoY

+14.80%

EPS YoY

−9.94%

FCF YoY

−31.12%

Revenue CAGR 3Y

+7.38%

EPS CAGR 3Y

−17.72%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

CNY 0.21

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

CNY 0.00

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.02x

Current Ratio

4.23x

Quick Ratio

3.18x

Div Yield

0.89%

Div Rate

CNY 0.38

Div Growth 1Y

+35.71%

Financials snapshotView financials →

Revenue (TTM)

2.03B

Net Income (TTM)

196.83M

Op. CF (TTM)

471.20M

Next earningsNov 4, 2026 →

Latest newsMore news →

PharmaBlock Sciences announced plans to invest about 2 billion yuan to build a CDMO innovation base in Nanjing, with a project company to be established with Nanjing Jiangbei New Materials Science and Technology Park Co., Ltd.1d ago

PharmaBlock Sciences announced its first-half 2026 results: revenue of 1.059 billion yuan, up 15.19% year-on-year; net profit attributable to shareholders of 99.4449 million yuan, up 37.17%; non-GAAP net profit of 83.8883 million yuan, up 40.70%; and a proposed cash dividend of 1 yuan per 10 shares (tax included).26d ago

Similar companies

广电计量002967.SZ 深城交301091.SZ 义翘神州301047.SZ 信测标准300938.SZ 地铁设计003013.SZ 百普赛斯301080.SZ Find similar companies →

Latest newsMore news →

PharmaBlock Sciences announced plans to invest about 2 billion yuan to build a CDMO innovation base in Nanjing, with a project company to be established with Nanjing Jiangbei New Materials Science and Technology Park Co., Ltd.1d ago PharmaBlock Sciences announced its first-half 2026 results: revenue of 1.059 billion yuan, up 15.19% year-on-year; net profit attributable to shareholders of 99.4449 million yuan, up 37.17%; non-GAAP net profit of 83.8883 million yuan, up 40.70%; and a proposed cash dividend of 1 yuan per 10 shares (tax included).26d ago